Mipatrini, D., Montaldo, C., Bartolini, B., Rezza, G., Iavicoli, S., Ippolito, G., Zumla, A.
& Petersen, E. (2022).
'Disease X'-time to act now and prepare for the next pandemic threat.
European Journal of Public Health,
32(6), 841-842.
https://doi.org/10.1093/eurpub/ckac151
Iversen, B. R., Løkke, A.
, Bregnballe, V. & Rodkjær, L. Ø. (2022).
Does affiliation to a cross-sectorial lung team impact well-being, health-related quality of life, symptoms of anxiety and depression and patient involvement in patients with COPD? A randomised controlled trial.
Scandinavian Journal of Caring Sciences,
36(3), 730-741.
https://doi.org/10.1111/scs.13034
Gunst, J. D., Pahus, M. H., Rosás-Umbert, M., Lu, I. N., Benfield, T.
, Nielsen, H., Johansen, I. S.
, Mohey, R., Østergaard, L., Klastrup, V., Khan, M.
, Schleimann, M. H., Olesen, R., Støvring, H., Denton, P. W., Kinloch, N. N., Copertino, D. C., Ward, A. R., Alberto, W. D. C.
... Søgaard, O. S. (2022).
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial.
Nature Medicine,
28(11), 2424-2435.
https://doi.org/10.1038/s41591-022-02023-7
Gruell, H.
, Gunst, J. D., Cohen, Y. Z.
, Pahus, M. H., Malin, J. J., Platten, M., Millard, K. G.
, Tolstrup, M., Jones, R. B., Conce Alberto, W. D., Lorenzi, J. C. C., Oliveira, T. Y., Kümmerle, T., Suárez, I., Unson-O'Brien, C., Nogueira, L.
, Olesen, R., Østergaard, L., Nielsen, H.
... Søgaard, O. S. (2022).
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial.
The Lancet Microbe,
3(3), e203-e214.
https://doi.org/10.1016/S2666-5247(21)00239-1
Petersen, E., Ntoumi, F., Hui, D. S., Abubakar, A., Kramer, L. D., Obiero, C., Tambyah, P. A., Blumberg, L., Yapi, R., Al-Abri, S., Pinto, T. D. C. A., Yeboah-Manu, D., Haider, N., Asogun, D., Velavan, T. P., Kapata, N., Bates, M., Ansumana, R., Montaldo, C. ... Zumla, A. (2022).
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
International Journal of Infectious Diseases,
114, 268-272.
https://doi.org/10.1016/j.ijid.2021.11.040
Oriol-Tordera, B., Esteve-Codina, A., Berdasco, M.
, Rosás-Umbert, M., Gonçalves, E., Duran-Castells, C., Català-Moll, F., Llano, A., Cedeño, S., Puertas, M. C.
, Tolstrup, M., Søgaard, O. S., Clotet, B., Martínez-Picado, J., Hanke, T., Combadiere, B., Paredes, R., Hartigan-O'Connor, D., Esteller, M. ... Ruiz-Riol, M. (2022).
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcome.
EBioMedicine,
78, Article 103956.
https://doi.org/10.1016/j.ebiom.2022.103956
Sperling, S., Fløe, A., Leth, S., Hyldgaard, C., Gissel, T., Topcu, A., Kristensen, L., Sønderskov, L. D., Schmid, J. M., Jensen-Fangel, S. & Bendstrup, E. (2022).
Fatigue Is a Major Symptom at COVID-19 Hospitalization Follow-Up.
Journal of Clinical Medicine,
11(9), Article 2411.
https://doi.org/10.3390/jcm11092411
Johansen, N. D., Modin, D., Nealon, J., Samson, S., Salamand, C.
, Larsen, C. S., Claggett, B. L., Solomon, S. D., Landray, M. J., Gislason, G. H., Køber, L., Jensen, J. U. S., Sivapalan, P., Vestergaard, L. S., Valentiner-Branth, P., Krause, T. G. & Biering-Sørensen, T. (2022).
Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial.
Pilot and Feasibility Studies,
8(1), Article 87.
https://doi.org/10.1186/s40814-022-01044-w
Suppli, C. H., Norman, A., Folkvardsen, D. B.
, Gissel, T. N., Weinreich, U. M., Koch, A.
, Wejse, C. & Lillebaek, T. (2022).
First outbreak of multi-drug resistant tuberculosis (MDR-TB) in Denmark involving six Danish-born cases.
International Journal of Infectious Diseases,
117, 258-263.
https://doi.org/10.1016/j.ijid.2022.02.017